LGALS7 抗体 (AA 31-100)
Quick Overview for LGALS7 抗体 (AA 31-100) (ABIN715076)
抗原
See all LGALS7 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 31-100
-
交叉反应
- 大鼠
-
预测反应
- Human,Mouse
-
纯化方法
- Purified by Protein A.
-
免疫原
- KLH conjugated synthetic peptide derived from human Galectin 7
-
亚型
- IgG
-
-
-
-
应用备注
-
WB 1:300-5000
ELISA 1:500-1000
IHC-P 1:200-400
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200
ICC 1:100-500 -
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1 μg/μL
-
缓冲液
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
储存液
- ProClin
-
注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
储存条件
- 4 °C,-20 °C
-
储存方法
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
-
有效期
- 12 months
-
-
- LGALS7 (Galectin 7 (LGALS7))
-
别名
- Galectin 7
-
背景
-
Synonyms: GAL7, LGALS7A, Galectin-7, Gal-7, HKL-14, PI7, p53-induced gene 1 protein, LGALS7, PIG1
Background: Could be involved in cell-cell and/or cell-matrix interactions necessary for normal growth control. Pro-apoptotic protein that functions intracellularly upstream of JNK activation and cytochrome c release.
-
基因ID
- 3963
-
UniProt
- P47929
抗原
-